Home Newsfeeds Wolfe Research Downgrades Regal Rexnord to Peer Perform

Wolfe Research Downgrades Regal Rexnord to Peer Perform

Wolfe Research analyst Nigel Coe downgrades Regal Rexnord (NYSE:RRX) from Outperform to Peer Perform.

byBenzinga Newsdesk

December 1, 2022

1 minute read

Wolfe Research analyst Nigel Coe downgrades Regal Rexnord (NYSE:RRX) from Outperform to Peer Perform.

ABVC BioPharma Says Phase II Vitargus Clinical Trial Receives Local Ethics Committee Approval In Thailand

By Benzinga Newsdesk

August 18, 8:33 AM

ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that, on August 2, 2022, approval was

ABVC

FDA Clears Insulet’s Omnipod 5 Automated Insulin Delivery System For Preschool Children

By Ragothaman Srinivasan

August 22, 7:39 AM

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D).

PODD

Optical Cable Q3 EPS $(0.05) Down From $0.71 YoY, Sales $17.40M Up From $15.63M YoY

By Benzinga Newsdesk

September 12, 8:24 AM

Optical Cable (NASDAQ:OCC) reported quarterly losses of $(0.05) per share. This is a 107.04 percent decrease over earnings of $0.71 per share from the same period last year. The company reported $17.40 million in sales

OCC

Adverum Biotechnologies Completes IND Amendment And Prepares To Initiate The Phase 2 LUNA Trial Of ADVM-022 In Wet AMD

By Benzinga Newsdesk

July 6, 4:10 PM

- Cash runway extended into 2025 due to corporate restructuring to prioritize the clinical development of ADVM-022 and provide additional resources beyond anticipated one-year topline results of the Phase 2 LUNA trial -

ADVM

Wolfe Research Downgrades Regal Rexnord to Peer Perform

Related Posts

ABVC BioPharma Says Phase II Vitargus Clinical Trial Receives Local Ethics Committee Approval In Thailand

FDA Clears Insulet’s Omnipod 5 Automated Insulin Delivery System For Preschool Children

Optical Cable Q3 EPS $(0.05) Down From $0.71 YoY, Sales $17.40M Up From $15.63M YoY

Adverum Biotechnologies Completes IND Amendment And Prepares To Initiate The Phase 2 LUNA Trial Of ADVM-022 In Wet AMD